Deregulation of apoptosis pathway is one of crucrial mechanisms causing tumorigenesis and driving cancer progression. Survivin is a member of the inhibitor of apoptosis, IAP gene family. It plays a dual role in both cell death suppression and cell cycle regulation at the G2/M phase. Its expression also contributes to resistance to chemo- and radiotherapy of the cancer cells. This study was aimed at determination of surviving mRNA expression semiquantitatively comparing to the surviving expression in tumor tissue of the nonsmall cell lung cancer. Correlation between survivin mRNA content and expression of the commercially available survivin in the tumor tissue and pathlogical parameters is also evaluated proving the significance of survivin in cancer diagnosis and prognosis. 22 cases of surgically resected nonsmall cell lung cancer were included during the year 2005 and the early 2006. Total RNA was extracted from fresh frozen tissues of both cancer and corresponding normal lung tissues. The formalin-fixed, paraffin-embedded cancer tissue has been tested with commercially available suvivin antibody immunohistochemcially. The correlation between mRNA expression and protein expression was evaluated with pathological parameters using Chi-squre test. Selective survivin expression in the lung cancer tissue not in the normal lung tissue makes it a potential diagnostic marker however, the prognostic marker to select the cases that might be chemoresponsive needs to verify with the other markers.